Article History
Received: 23 April 2020
Accepted: 13 July 2020
First Online: 30 July 2020
Competing interests
: J.F. and R.S. are full-time employees of Sotio. G.K. has been holding research contracts with Bayer Healthcare, Genentech, Glaxo Smyth Kline, Institut Mérieux, Lytix Pharma, PharmaMar, Sotio and Vasculox. He is on the Board of Directors of the Bristol Myers Squibb Foundation France, member of the Scientific Advisory Board of The Longevity Labs, and scientific co-founder of everImmune, Samsara therapeutics and Therafast Bio. L.G. received research support from Lytix and Phosplatin, consulting fees from OmniSEQ, Astra Zeneca, Inzen and the Luke Heller TECPR2 Foundation, and he is member of Scientific Advisory Committees for Boehringer Ingelheim, The Longevity Labs and OmniSEQ.